- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07928349
Social Media Perceptions Among Young Adults With Cancer - Online Experiment 2 (SIYAMOS2)
Young adults with cancer experience more loneliness than their non-cancer peers or older cancer survivors. Positive psychology interventions have promise to increase social connectedness; however, evidence-based interventions should be tailored for young adults with cancer and designed for social media. The investigators conducted an online experiment with young adults with cancer (ages 22-39) to examine the most promising message types with personal stories to identify a suite of intervention messages that encourage positive, in-person social interactions with strangers and acquaintances (i.e., weak ties).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This is a between-person online experiment where connected peer advocate and clinician framing and cancer-specific personal stories were used for intervention messages compared to control messages. Participants were randomized (Qualtrics built-in randomizer) evenly to 1 of 4 message panels: intervention panel 1, intervention panel 2, control panel 1, or control panel 2. The investigators hypothesized that intervention messages (vs. control) would lead to greater perceived message effectiveness and intended message reactions.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
North Carolina
-
Chapel Hill, North Carolina, États-Unis, 27599
- University of North Carolina at Chapel Hill, Department of Radiation Oncology
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Participants must be 22-39 years old at the time of the study
- Participants must have received a cancer diagnosis at any point between ages 15-39
- Participants must self-report low-to-moderate psychosocial quality of life (QOL), defined as an average rating of 4 or lower on the National Institutes of Health's (NIH's) validated 2-item Patient Reported Outcomes Measurement Information System (PROMIS) global mental health scale (two 5-point items)
- Participants must use social media
Exclusion Criteria:
- None
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Cancer Peer and Clinician Messages
Participants are randomized to 1 of 2 intervention panels to view and rate 9 social media posts: 6 from socially connected cancer peer advocates and 3 from clinicians, each with a cancer story and advice to have positive in-person interactions with people they barely know. |
Participants were randomized to 1 of 4 message panels (intervention 1, intervention 2, control 1, control 2). |
|
Comparateur actif: Arm 2: Control - Public Service Announcement Messages
Participants are randomized to 1 of 2 control panels and view and rate 9 public service announcement posts about food safety or password safety. |
Participants were randomized to 1 of 4 message panels (intervention 1, intervention 2, control 1, control 2). |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Perceived Message Effectiveness for In-Person Interactions (Single-Item Self-Report, 5-Point Scale)
Délai: Baseline, Up to 1 hour
|
After viewing each of 9 social media posts, participants answered one item: "How much does this post make you want to interact in person with people you barely know? (This doesn't include online interactions.)" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived message effectiveness for in-person interactions. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Positive Affect (Single-Item Self-Report, 5-Point Scale)
Délai: Baseline, Up to 1 hour
|
After viewing each of 9 social media posts, participants answered one item: "How good does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater positive affect. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
|
Perceived Social Presence (single item adapted from Lazard et al., 2020; 5-point agreement scale)
Délai: Baseline, Up to 1 hour
|
After viewing each of 9 social media posts, participants answered one item: "When viewing this post, how much do you feel as if someone is talking to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived social presence. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
|
Message Relevance (Single Item Adapted From Jensen et al., 2024; 5-Point Scale)
Délai: Baseline, Up to 1 hour
|
After viewing each of 9 social media posts, participants answered one item: "How relevant is this post to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived relevance. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
|
Perceived Message Effectiveness for Online Interactions (Single-Item Self-Report, 5-Point Scale)
Délai: Baseline, Up to 1 hour
|
After viewing each of 9 social media posts, participants answered one item: "How much does this post make you want to interact online with people you barely know? (Online includes on social media.)" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived message effectiveness for online interactions. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
Collaborateurs et enquêteurs
Collaborateurs
Les enquêteurs
- Chercheur principal: Allison J Lazard, PhD, UNC Lineberger Comprehensive Cancer Center
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- SIYAMOS2 Online Experiment 2
- R01CA276176 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .